• Adults​ ​With​ ​CF

  Cystic Fibrosis and the Epithelium Sodium Channel: Could SPX-101 Fix It?

  Posted by Cystic Fibrosis News Moderator on September 13, 2019 at 9:02 am

  

  In this column, Reid D’Amico shares background on an investigational CF therapy called SPX-101, developed by Spyryx Biosciences, which has shown promise in early animal studies. Click here to read more from Reid.

  What did you think of this column?

  Cystic Fibrosis News Moderator replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply